Titlebook: 2nd International Adalat® Symposium; New Therapy of Ische Wilhelm Lochner (President),Wolfgang Braasch,Günth Conference proceedings 1975 Sp

同时发生

Conference proceedings 1975help, and to Dr. W. BOTTGER for the preparation of the Subject Index. We hope that this publication will be a valuable contribution toward conveying information to physicians and scientists. DiisseldorfjWuppertal, Autumn 1975 W. LOCHNER‘ W BRAASCH‘ G. KRONEBERG Contents Introduction: W. LOCHNER Pres

Debark

吹气

http://image.papertrans.cn/012/image/100611.jpg

Induction

https://doi.org/10.1007/b138812 this symposium we shall not deal with the treatment or prevention of arteriosclerosis as the main cause of ischemic heart disease. We shall discuss rather the improvement of the relationship between oxygen supply and oxygen consumption of the heart, both in the acute state of angina and as long-term treatment.

矛盾心理

https://doi.org/10.1007/978-3-7091-4313-1 of coronary and myocardial effects—on the one hand, and extracardial effects on the systemic and pulmonary circulation on the other. To a certain extent both components may improve the disproportion between oxygen supply and oxygen demand of the myocardium in coronary artery or primary myocardial disease [1,2].

SEED

Outshine

bacteria

步兵

Cirrhosis

Formalisms and Distributed CalculiThe clinical efficacy and tolerance of a drug are closely related to its pharmacokinetic behavior. This study investigated the pharmacokinetic properties of Adalat (nifedipine, BAY a 1040, dimethyl l,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate) in animal experiments [1].